title: Thalidomide induced impotence in male hematology patients: a common but ignored complication?
abstract: Thalidomide has become an important agent in the treatment of myeloma. However, thalidomide induced erectile dysfunction is a serious complication which has received very little attention. In our hematology department, 6 out of 11 male patients developed erectile dysfunction (grade 3 in 5/6) within 4 weeks of starting thalidomide. Our results suggest that thalidomide induced impotence is a common complication in male hematology patients.
authors.forename: Philip T
authors.initials: PT
authors.lastname: Murphy
authors.forename: John Rory
authors.initials: JR
authors.lastname: O'Donnell
mesh_terms: D000328:Adult; D000368:Aged; D007172:Erectile Dysfunction / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D013792:Thalidomide